The Deleterious Effects of Hyperglycemia on Platelet Function in Diabetic Patients With Acute Coronary Syndromes. Mediation by Superoxide Production, Resolution With Intensive Insulin Administration

Journal of the American College of Cardiology

Volumn 49, Issue 3, 2007, Pages 304-310

  Worthley, Matthew I ^a   Holmes, Andrew S ^a   Willoughby, Scott R ^a   Kucia, Angela M ^a   Heresztyn, Tamila ^a   Stewart, Simon ^a   Chirkov, Yuliy Y ^a   Zeitz, Christopher J ^a   Horowitz, John D ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; N(G),N(G) DIMETHYLARGININE; NEUTRAL INSULIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; ORAL ANTIDIABETIC AGENT; ORGANIC NITRATE; SULFONYLUREA; SUPEROXIDE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BIOAVAILABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DRUG DOSE ESCALATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; LUMINESCENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PLATELET ACTIVATION; TREATMENT OUTCOME;

EID: 33846261168     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.08.053     Document Type: Article

References (36)

1. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 30 (1997) 171-179
2. Malmberg K., Yusuf S., Gerstein H.C., et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102 (2000) 1014-1019
3. Malmberg K., Norhammer A., Wedel H., and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
4. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
5. Tesfamariam B., Brown M.L., and Cohen R.A. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87 (1991) 1643-1648
6. Shige H., Ishikawa T., Suzukawa M., et al. Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus. Am J Cardiol 84 (1999) 1272-1274
7. Ceriello A. Oxidative stress and glycemic regulation. Metabolism 49 (2000) 27-29
8. Bonnefort-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5 (2002) 561-568
9. Lin K.Y., Ito A., Asagami T., et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 106 (2002) 987-992
10. Aoki I., Shimoyama K., Aoki N., et al. Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes. J Am Coll Cardiol 27 (1996) 560-566
11. Turk Z., Flego I., and Kerum G. Platelet aggregation in type 1 diabetes without microvascular disease during continuous subcutaneous insulin infusion. Horm Metab Res 28 (1996) 95-100
12. Osende J.I., Badimon J.J., Fuster V., et al. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol 38 (2001) 1307-1312
13. Gresele P., Guglielmini G., DeAngelis M., et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 41 (2003) 1013-1020
14. Oswald G.A., Smith C.C., Delamothe A.P., Betteridge D.J., and Yudkin J.S. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 59 (1988) 663-671
15. Westerbacka J., Yki-Jarvinen H., Turpeinen A., et al. Inhibition of platelet-collagen interaction an in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler Thromb Vasc Biol 22 (2002) 167-172
16. Anfossi G., Massucco P., Mattiello L., et al. Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations. Thromb Res 82 (1996) 57-68
17. Trovati M., Massucco P., Mattiello L., et al. The insulin-induced increase of guanosine-3′,5′-cyclic monophosphate in human platelets is mediated by nitric oxide. Diabetes 45 (1996) 768-770
18. Chirkov Y.Y., Holmes A.S., Chirkova L.P., and Horowitz J.D. Nitrate resistance in platelets from patients with stable angina pectoris. Circulation 100 (1999) 129-134
19. Chirkov Y.Y., Holmes A.S., Willoughby S.R., et al. Stable angina and acute coronary syndromes are associated with nitric oxide resistance in platelets. J Am Coll Cardiol 37 (2001) 1851-1857
20. Malmberg K., Ryden L., Efendic S., et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
21. Malmberg K., Ryden L., Wedel H., et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26 (2005) 650-661
22. Willoughby S.R., Stewart S., Chirkov Y.Y., Kennedy J.A., Holmes A.S., and Horowitz J.D. Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide. Eur Heart J 23 (2002) 1946-1954
23. Chirkov Y.Y., Chirkova L.P., and Horowitz J.D. Nitrate tolerance at the platelet level in patients with angina pectoria. Am J Cardiol 80 (1997) 128-131
24. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J Immunol Methods 97 (1987) 209-213
25. Chirkov Y.Y., Naujalis J.I., Sage R.E., and Horowitz J.D. Antiplatelet effects of nitroglycerin in healthy subjects and in patients with stable angina pectoris. J Cardiovasc Pharmacol 21 (1993) 384-389
26. G′-dimethyl-L-arginine in plasma by liquid chromatography as AccQ-Fluor fluorescent derivatives. J Chromatogr B 805 (2004) 325-329
27. Van den Berghe G., Wouters P.J., Bouillon R., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
28. The CREATE-ECLA Trial Group. Effect of glucose-insulin potassium infusion on mortality in patients with ST-segment elevation myocardial infarction. The CREATE-ECLA randomised controlled trial. JAMA 293 (2005) 437-446
29. Inoguchi T., Li P., Umeda F., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
30. Mohanty P., Hamouda W., Garg R., Aljada A., Ghanim H., and Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 85 (2000) 2970-2973
31. Paiva H., Lehtimaki T., Laakso J., et al. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy. Metabolism 52 (2003) 303-307
32. Cooke J.C. Asymmetric dimethylarginine. The über marker?. Circulation 109 (2004) 1813-1819
33. Vaikonnen V.-P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358 (2001) 2127-2128
34. Willoughby S.R., Stewart S., Holmes A.S., Chirkov Y.Y., and Horowitz J.D. Platelet nitric oxide responsiveness. Novel prognostic marker in scute coronary syndromes: platelet nitric oxide responsiveness. Atheroscler Thromb Vasc Biol 25 (2005) 2661-2666
35. De La Cruz J.P., Arrebola M.M., Villalobos M.A., et al. Influence of glucose concentration on the effects of aspirin ticlopidine and clopidogrel on platelet function and platelet-subendothelium interaction. Eur J Pharmacol 484 (2004) 19-27
36. Trovati M., and Anfossi G. Influcence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J Diabetes Complications 16 (2002) 35-40